Key metrics and charts across all fundamental categories.
Stock price and market valuation
CTRA trades at $32.56, a 12.7% increase year-over-year. Market capitalization stands at $24.71B, up 13.1% from the prior year. Track CTRA price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$7.66B in TTM revenue grew 26.7% YoY, reaching $2.38B last quarter. TTM EBITDA of $4.82B on operating income of $646.00M shows growth is flowing through. Net income of $1.67B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $24.63B in assets and $3.26B in long-term debt, the D/E of 0.2 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 14.8x P/E, the stock trades below market averages — potentially undervalued. P/S of 3.2x and P/B of 1.6x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
Operating efficiency and return metrics
Op. margin of 27.1% is down 7.7% YoY — costs are rising relative to revenue. Net margin at 19.6%. ROE of 11.0% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $991.00M on $1.65B in operating cash flow. The FCF / Net Income ratio of 0.6x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $485.00M provide financial flexibility. Share count is stable — no dilution or buyback activity.
